高危非致残性脑血管病及其防控关键技术与应用——2016年度国家科学技术进步二等奖

doi:10.3969/j.issn.1006-7795.2017.01.001

首都医科大学学报 ›› 2017, Vol. 38 ›› Issue (1): 1-5.doi: 10.3969/j.issn.1006-7795.2017.01.001

高危非致残性脑血管病及其防控关键技术与应用——2016年度国家科学技术进步二等奖

王伊龙, 赵性泉, 王拥军

首都医科大学附属北京天坛医院神经内科, 北京 100050

收稿日期:2017-01-09 出版日期:2017-01-21 发布日期:2017-01-20
通讯作者: 王拥军 E-mail:yongjunwang111@aliyun.com
基金资助:
国家科技支撑计划（2006BAI01A11），北京市科技计划（D101107049310005，D101107049310006，D09050703560904，D0905004040231，10910120119）。

Strategies for management of high risk nondisabling cerebrovascular events

Wang Yilong, Zhao Xingquan, Wang Yongjun

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

Received:2017-01-09 Online:2017-01-21 Published:2017-01-20

摘要/Abstract

摘要： 脑血管病已成为我国居民死亡和成人致残的首位病因，其高复发、高致残的主要原因是适宜干预人群不清、高危预警策略不明、循证治疗手段贫乏、个体化诊疗技术欠缺等。王拥军教授团队在开展大样本量社区人群调查和住院队列研究的基础上，发现了我国脑血管病防治的适宜且需重点干预人群，并以此为突破口提出了“高危非致残性脑血管病”概念，建立了高危风险预警体系，开创了优化的“双重抗血小板”治疗新技术，使高危患者90 d复发风险在不增加出血的前提下降低32%。成果改写了国际、国内指南，在临床得到广泛推广应用，已累计减少74万例脑血管病复发病例，累计降低医疗花费150亿人民币。

关键词: 脑血管病, 高危非致残, 预警, 诊断, 治疗

Abstract: Cerebrovascular events have become the most common cause for death or dependency of Chinese population. Risk assessment model for stroke recurrence was insufficient and effective treatment strategy was lacking. Prof. Yongjun Wang et al carried out a population-based survey and a cohort study with large sample, presented the concept of "high risk patients with acute nondisabling cerebrovascular events", established a risk accessment system for stroke, and found a new dual antiplatelet method which significantly decreased the risk of stroke recurrence by 32% without increasing bleeding events. The new method had been applied in the clinical practice widely, decreased stroke recurrence in 740 000 cases and reduced medical cost by 15 billion yuan.

Key words: cerebrovascular disease, high risk nondisabling, risk, diagnosis, treatment

中图分类号:

R743.3

王伊龙, 赵性泉, 王拥军. 高危非致残性脑血管病及其防控关键技术与应用——2016年度国家科学技术进步二等奖[J]. 首都医科大学学报, 2017, 38(1): 1-5.

Wang Yilong, Zhao Xingquan, Wang Yongjun. Strategies for management of high risk nondisabling cerebrovascular events[J]. Journal of Capital Medical University, 2017, 38(1): 1-5.

参考文献

[1] Johnston S C, Mendis S, Mathers C D, et al. Global variation in stroke burden and mortality:estimates from monitoring, surveillance, and modelling[J]. Lancet Neurol, 2009,8(4):345-354.
[2] Wang Y, Zhao X, Jiang Y, et al. Prevalence, knowledge, and treatment of transient ischemic attacks in china[J]. Neurology,2015, 84(23):2354-2361.
[3] Wang Y, Cui L, Ji X, et al. The China national stroke registry for patients with acute cerebrovascular events:design, rationale, and baseline patient characteristics[J]. Int J Stroke,2011,6(4):355-361.
[4] Li J, Wang Y, Lin J, et al. Soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack[J]. Stroke, 2015,46(7):1990-1992.
[5] Lin J, Zheng H, Cucchiara B L, et al. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke[J]. Neurology,2015, 85(18):1585-1591.
[6] Wang Y, Zhao X, Liu L, et al. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China:The Chinese intracranial atherosclerosis (CICAS) study[J]. Stroke,2014,45(3):663-669.
[7] Meng X, Wang Y, Liu L, et al. Validation of the ABCD²-I score to predict stroke risk after transient ischemic attack[J]. Neurol Res,2011,33(5):482-486.
[8] Furie K L, Kasner S E, Adams R J. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack:a guideline for healthcare professionals from the American heart association/American stroke association[J].Stroke,2011,42(1):227-276.
[9] Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack[J]. N Engl J Med, 2013,369(1):11-19.
[10] 中华医学会神经病学会, 中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J].中华神经科杂志,2015,48(4):258-273.
[11] Poisson S N, Schardt T Q, Dingman A, et al. Etiology and treatment of arterial ischemic stroke in children and young adults[J]. Curr Treat Options Neurol, 2014,16(10):315.
[12] Coutts SB1, Wein T H, Lindsay M P. Canadian stroke best practice recommendations:secondary prevention of stroke guidelines, update 2014[J]. Int J Stroke, 2015, 10(3):282-291.
[13] Wang Y, Pan Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial:One-year outcomes[J]. Circulation, 2015,132(1):40-46.
[14] Wang X, Zhao X, Johnston S C, et al. Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke:CHANCE substudy[J]. Neurology, 2015,85(7):573-579.
[15] Wong K S, Wang Y, Leng X, et al. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack:an updated systematic review and meta-analysis[J]. Circulation, 2013,128(15):1656-1666.
[16] Wang Y, Zhao X, Lin J, et al. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack[J]. JAMA, 2016,316(1):70-78.
[17] Li J, Wang Y, Wang D, et al. Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke[J]. Neurology,2015,84(13):1330-1336.

高危非致残性脑血管病及其防控关键技术与应用——2016年度国家科学技术进步二等奖

Strategies for management of high risk nondisabling cerebrovascular events

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王文文, 蔡昱, 贾双双, 翟建军. 驱动蛋白家族成员2C与卵巢癌化学药物治疗耐药的相关性[J]. 首都医科大学学报, 2023, 44(1): 143-147.
[2]	曹富雨, 季长高. 术后快速康复对全膝关节置换术后功能的影响[J]. 首都医科大学学报, 2023, 44(1): 167-171.
[3]	罗诗雨, 李眉, 罗莎, 王爽, 张娟, 李萌, 南潇, 鲜军舫. ¹⁸F-FDG PET/CT在脉络膜黑色素瘤与脉络膜转移癌鉴别诊断中的应用价值[J]. 首都医科大学学报, 2022, 43(6): 867-872.
[4]	徐潇漪, 王国勤, 程虹, 赵智睿, 董鸿瑞, 孙丽君. 小剂量利妥昔单抗治疗特发性膜性肾病的疗效及其影响因素[J]. 首都医科大学学报, 2022, 43(5): 680-686.
[5]	钱坤, 赵昕, 谭晓刚, 田笑如, 刘幸生, 张毅. 电子计算机断层扫描引导下经皮肺穿刺活检磨玻璃结节的诊断价值[J]. 首都医科大学学报, 2022, 43(4): 558-563.
[6]	谭晓刚, 张毅. 电磁导航支气管镜在肺外周病变诊断及治疗的临床应用[J]. 首都医科大学学报, 2022, 43(4): 570-575.
[7]	田明, 孔秋, 候晓晓, 苗劲蔚. 良、恶性卵巢甲状腺肿的临床和病理特征分析[J]. 首都医科大学学报, 2022, 43(3): 343-349.
[8]	赵越, 阮祥燕, 程姣姣, 谷牧青, 许新, 王月姣. 乳腺癌中PGRMC1表达与临床病理参数的相关性[J]. 首都医科大学学报, 2022, 43(3): 350-356.
[9]	鞠蕊, 阮祥燕, 代荫梅, 白勇涛, 杨瑜, 许新, 程姣姣, 杨幸子, 施琰红, 孙艳华, 李瑞玲. 女性性功能障碍的影响因素研究[J]. 首都医科大学学报, 2022, 43(3): 357-363.
[10]	侯磊, 王小新, 刘丽恒, 张为远, 王欣. 134例生长受限胎儿产前诊断结果分析[J]. 首都医科大学学报, 2022, 43(3): 375-379.
[11]	刘珊珊, 房萌, 朱虹, 尹冬青, 赵燕, 赵爽, 贾竑晓. 2010年和2019年双相情感障碍住院患者的临床特征和未治疗持续时间的因素分析[J]. 首都医科大学学报, 2022, 43(3): 415-420.
[12]	李雪, 邢洁, 张倩, 李鹏, 吕富靖, 张澍田. 窄带成像技术联合放大内镜JES分型对早期食管癌的诊断价值[J]. 首都医科大学学报, 2022, 43(2): 210-215.
[13]	任艳萍, 张俊岩, 吴涵, 罗炯, 杨春林, 马辛, 姜玮. 磁惊厥治疗与无抽搐电痉挛治疗抑郁发作的早期疗效及对认知功能的影响[J]. 首都医科大学学报, 2022, 43(2): 239-243.
[14]	姚舒洋, 李小雪, 王淳秀, 张毅. 埃克替尼联合抗血管药物一线治疗EGFR突变晚期肺腺癌的单中心研究[J]. 首都医科大学学报, 2022, 43(2): 289-293.
[15]	孙昊, 郑美丽, 郭宗生, 张智勇, 李晓涛. 左心室收缩功能对经皮冠状动脉介入治疗的急性下壁ST段抬高型心肌梗死患者预后的影响[J]. 首都医科大学学报, 2022, 43(2): 305-310.